These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17620979)

  • 1. Device-guided slow breathing as a nonpharmacological approach to antihypertensive treatment in type 2 diabetics.
    Gavish B
    J Hypertens; 2007 Aug; 25(8):1742; author reply 1742-3. PubMed ID: 17620979
    [No Abstract]   [Full Text] [Related]  

  • 2. Device-guided slow breathing as a non-pharmacological approach to antihypertensive treatment: efficacy, problems and perspectives.
    Parati G; Carretta R
    J Hypertens; 2007 Jan; 25(1):57-61. PubMed ID: 17143174
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating hypertension in type II diabetic patients with device-guided breathing: a randomized controlled trial.
    Schein MH; Gavish B; Baevsky T; Kaufman M; Levine S; Nessing A; Alter A
    J Hum Hypertens; 2009 May; 23(5):325-31. PubMed ID: 19005477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RESPeRATE: nonpharmacological treatment of hypertension.
    Sharma M; Frishman WH; Gandhi K
    Cardiol Rev; 2011; 19(2):47-51. PubMed ID: 21285661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypertension in patients with type-2 diabetes mellitus.
    Kjeldsen SE; Os I; Farsang C; Mallion JM; Hansson L; Sleight P
    Blood Press; 2000; 9(6):363-4. PubMed ID: 11212066
    [No Abstract]   [Full Text] [Related]  

  • 6. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function.
    Marchesi C; Maresca AM; Solbiati F; Franzetti I; Laurita E; Nicolini E; Gianni M; Guasti L; Marnini P; Venco A; Grandi AM
    Am J Hypertens; 2007 Oct; 20(10):1079-84. PubMed ID: 17903691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Device-guided breathing in the home setting: technology, performance and clinical outcomes.
    Gavish B
    Biol Psychol; 2010 Apr; 84(1):150-6. PubMed ID: 20193729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure responses to exercise in type II diabetes mellitus patients with masked hypertension.
    Kramer CK; Leitão CB; Canani LH; Ricardo ED; Pinto LC; Gross JL
    J Hum Hypertens; 2009 Sep; 23(9):620-2. PubMed ID: 19322204
    [No Abstract]   [Full Text] [Related]  

  • 9. The hottest diabetes research. Part 2.
    Kordella T
    Diabetes Forecast; 2004 Nov; 57(11):47-9. PubMed ID: 15510378
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension in the elderly: new and old evidence that treatment may benefit the old.
    Fagard RH
    J Nephrol; 2009; 22(5):580-6. PubMed ID: 19809990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From macro- to microcirculation: benefits in hypertension and diabetes.
    Agabiti-Rosei E
    J Hypertens Suppl; 2008 Sep; 26(3):S15-9. PubMed ID: 19363848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension "essentials".
    Gottlieb SH
    Diabetes Forecast; 2002 Jul; 55(7):40-2. PubMed ID: 14765438
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased arterial stiffness is associated with reduced plasma levels of beta-carotene in treated hypertensive patients with type 2 diabetes mellitus.
    Chung HK; Kang B; Lee JH; Shim JY; Park S; Lee SH; Park YK; Park E; Chung N; Shin MJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):e9-e11. PubMed ID: 19505810
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
    Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent predictors of cardiac parasympathetic dysfunction in type 2 diabetes mellitus.
    Subbalakshmi NK; Adhikari PM; Rajeev A; Asha K; Jeganathan PS
    Singapore Med J; 2008 Feb; 49(2):121-8. PubMed ID: 18301839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory blood pressure vs. office blood pressure in type 2 diabetes.
    Pistrosch F
    Am J Hypertens; 2008 Apr; 21(4):372. PubMed ID: 18369353
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes.
    Migdalis IN
    Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):105-14. PubMed ID: 17974100
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
    Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
    [No Abstract]   [Full Text] [Related]  

  • 19. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation.
    Franjic B; Marwick TH
    J Hum Hypertens; 2009 Nov; 23(11):709-17. PubMed ID: 19516273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of white-coat hypertension on microvascular complications in type 2 diabetes: response to Kramer et al.
    Eguchi K; Kario K
    Diabetes Care; 2009 Feb; 32(2):e24; author reply e25. PubMed ID: 19171733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.